Petkana V.
- Country
- Bulgaria
- Department
- Second Internal Department
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Efficacy and Safety of Finerenone in Reducing Morbidity and Mortality in Heart Failure Patients with LVEF ≥40% Hospitalized for Acute Decompensated Heart Failure
- Evaluation of Baxdrostat and Dapagliflozin on Heart Failure Incidence and Cardiovascular Mortality in High-Risk Patients: A Phase III Randomized Controlled Trial
Data & Insights
Has run more than one trial at 159 of 711 partner sites.
Specializations
Cardiovascular Prevention
The investigator specializes in preventive cardiology, with particular emphasis on heart failure risk management and innovative therapeutic combinations. Their research explores preventive strategies using combination therapies including baxdrostat and dapagliflozin for patients at elevated risk of developing cardiac complications.
- Heart Failure Prevention
- Cardiovascular Mortality Risk Reduction
- Combination Therapy Approaches
Their work encompasses comprehensive cardiovascular risk assessment and preventive interventions in high-risk populations.
Stroke Prevention
The investigator focuses on advancing therapeutic approaches for stroke prevention in atrial fibrillation. Their research involves evaluating novel anticoagulation strategies using asundexian compared to established treatments for preventing stroke and systemic embolism.
- Atrial Fibrillation Management
- Anticoagulation Therapy
- Stroke Risk Reduction
Their expertise extends to bleeding risk assessment and optimization of antithrombotic treatments in cardiac patients.
Clinical Therapeutics
The investigator's work centers on comparative therapeutic effectiveness in cardiovascular medicine. They evaluate novel pharmaceutical agents against established treatments, focusing on both efficacy and safety profiles in cardiovascular disease prevention.
- Therapeutic Comparative Studies
- Safety Profile Assessment
- Risk-Benefit Analysis
Their research encompasses comprehensive evaluation of cardiovascular therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.